The forecast comes weeks after the drugmaker stunned investors with weaker-than-expected sales for its weight-loss drug ...
The company said last month that it expected to report sales of diabetes drug Mounjaro and weight-loss treatment Zepbound ...
Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, as it prepares to launch its popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results